InvestorsObserver
×
News Home

What is Wall Street's Target Price for P3 Health Partners Inc (PIII) Stock Thursday?

Thursday, August 31, 2023 10:28 AM | InvestorsObserver Analysts

Mentioned in this article

What is Wall Street's Target Price for P3 Health Partners Inc (PIII) Stock Thursday?

Wall Street is positive on P3 Health Partners Inc (PIII). On average, analysts give P3 Health Partners Inc a Buy rating. The average price target is $3.5, which means analysts expect the stock to increase by 60.55% over the next twelve months. That average ranking earns P3 Health Partners Inc an Analyst Rating of 36, which is better than 36% of stocks based on data compiled by InvestorsObserver.

Overall Score - 4
Wall Street analysts are rating PIII a Buy today. Find out what this means to you and get the rest of the rankings on PIII!

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers. InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With P3 Health Partners Inc Stock Today?

P3 Health Partners Inc (PIII) stock is trading at $2.18 as of 10:18 AM on Thursday, Aug 31, an increase of $0.21, or 10.66% from the previous closing price of $1.97. The stock has traded between $1.99 and $2.20 so far today. Volume today is high. So far 405,845 shares have traded compared to average volume of 312,562 shares. Click Here to get the full Stock Report for P3 Health Partners Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App